Highlights
NYSE: ZYME       Zymeworks Inc
Last Price Today's Change   Day's Range   Trading Volume
38.12   +0.74 (1.98%)  35.94 - 39.82  762,500

Overview

 
Avg Volume (4 weeks):511,173
4 Weeks Range:32.771 - 39.82
4 Weeks Price Volatility (%):
75.88%
52 Weeks Range:17.60 - 52.75
52 Weeks Price Volatility (%):
58.38%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Zymeworks Inc is a clinical-stage biopharmaceutical company. It is dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer. The company's product candidate, ZW25, is a bispecific (dual-targeting) antibody being evaluated in an adaptive Phase 1 clinical trial, targeting two distinct domains of the human epidermal growth factor receptor 2, or HER2. Its design enables ZW25 to address patient populations with all levels of HER2 expression, including those with low to intermediate HER2-expressing tumors, who are otherwise limited to chemotherapy or hormone therapy.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4779  3343  551  179 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 6.57-0.21 
 NLY 6.16-0.18 
 SPY 304.32+1.35 
 BAC 24.12-0.74 
 ADAP 11.07+6.21 
 MRO 5.34-0.36 
 F 5.71-0.14 
 XLF 23.41-0.27 
 SQQQ 9.43-0.40 
 NERV 3.71-9.76 
Partners & Brokers